Louvain-la-Neuve, Belgium August 18, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announces it has signed a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL), to provide proton therapy training and education programs for IBA customers in Asia.
AEHL is a long-term customer of IBA, purchasing a Proteus®PLUS[1] proton therapy system in 2013 and successfully utilizing it in the treatment of cancer patients for more than three years. Since AHEL started its proton therapy operations at Apollo Proton Cancer Centres (APCC), it has gained significant expertise and experience in treating a wide range of tumor types IBA plans to leverage this experience, working with AEHL to provide a training and education program initiative, to aspiring proton therapy users in Asia and other parts of the world.
Olivier Legrain, Chief Executive Officer at IBA, said: “Over recent years, Apollo Hospitals has shown its expertise and enthusiasm by successfully organizing training symposia for the local and international proton therapy experts’ community. We look forward to collaborating with Apollo in order to provide high-quality training and education to our customers and prospects in Asia without them traveling to another continent.”
Dr. Prathap C Reddy, Founder and Chairman of Apollo Hospitals Enterprise Ltd, said: “An acute need for high-quality cancer care, coupled with an increasing prevalence of cancer cases in India, led to the creation of Apollo Cancer Centres (ACC) around three decades ago. Since then, ACC has continually introduced the finest and most advanced cancer care into India, with the most recent being bringing Proton Therapy to the region. Furthermore, in keeping with its resolute mission to raise the bar in cancer care for all in need, in association with IBA, the Apollo Proton Cancer Centre will be the first of its kind training and education program reference centre in Asia.”
*** Ends ***
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,600 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
About Apollo Hospital group
Apollo Hospitals is ranked amongst the best hospitals world-wide for providing advanced medical services. It has touched the lives of over 200 million patients from 140 countries. As Asia's integrated private healthcare services provider, Apollo Hospitals Enterprise Limited consists of Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and Telemedicine units across 50 countries. Apollo Hospitals have expanded its presence via Health Insurance Services, Global Projects Consultancy, Colleges of Nursing and Hospital Management.
About Apollo Proton Cancer Centre (APCC)
Apollo Proton Cancer Centre, is a 150-bedded most advanced cancer centre. It is the first and only Proton Centre in South Asia & the Middle East and it is India’s first JCI accredited Cancer hospital, which offers state-of-the-art cancer care.
At the bedrock of APCC's approach to treating cancer, is its robust multi-disciplinary platform; highly skilled professionals who come together to form a cancer management team (CMT). Each CMT is focused on delivering the best possible outcomes for their patients. An added feather in the cap is the recent launch of India's first & only site-specific Robotic Oncology Program. Today people from 147 countries come to India for cancer treatment at Apollo Cancer Centres and APCC. With the first & only Pencil Beam Proton Therapy Centre in South Asia & Middle East, Apollo Proton Cancer Centre has all that is needed to strengthen battle against cancer.
[1] Proteus®PLUS is the brand name of IBA Proteus®235.